Literature DB >> 19589433

Reflections of inflections in hypertrophic cardiomyopathy.

Mark V Sherrid1, Omar Wever-Pinzon, Ajay Shah, Farooq A Chaudhry.   

Abstract

The shape of Doppler velocity tracings in obstructive hypertrophic cardiomyopathy offers insights into its pathophysiology. Inflection points are the points on a curve where its shape changes from concave to convex, or vice versa. These dynamic systolic abnormalities are caused: 1) by the amplifying nature of the obstruction; and 2) by the adverse effect of the sudden imposition of afterload in midsystole. The midsystolic drop in left ventricular ejection velocities and the premature termination of longitudinal shortening are compelling evidence of the deleterious mechanical effect of obstruction on the ventricle. This dynamic systolic dysfunction, demonstrated on the Doppler curves, may contribute to heart failure symptoms and adverse outcome. In outflow obstruction, these abnormalities normalize after abolition of gradient. Therefore, their detection in an individual patient confirms obstruction as a therapeutic target.

Entities:  

Mesh:

Year:  2009        PMID: 19589433     DOI: 10.1016/j.jacc.2009.03.052

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  8 in total

Review 1.  Fluid dynamic aspects of ejection in hypertrophic cardiomyopathy.

Authors:  Ares Pasipoularides
Journal:  Hellenic J Cardiol       Date:  2011 Sep-Oct

Review 2.  Myocardial energy depletion and dynamic systolic dysfunction in hypertrophic cardiomyopathy.

Authors:  Julian O M Ormerod; Michael P Frenneaux; Mark V Sherrid
Journal:  Nat Rev Cardiol       Date:  2016-07-14       Impact factor: 32.419

Review 3.  The many faces of hypertrophic cardiomyopathy: from developmental biology to clinical practice.

Authors:  Iacopo Olivotto; Francesca Girolami; Stefano Nistri; Alessandra Rossi; Luigi Rega; Francesca Garbini; Camilla Grifoni; Franco Cecchi; Magdi H Yacoub
Journal:  J Cardiovasc Transl Res       Date:  2009-10-27       Impact factor: 4.132

4.  How does morphology impact on diastolic function in hypertrophic cardiomyopathy? A single centre experience.

Authors:  Gherardo Finocchiaro; Francois Haddad; Aleksandra Pavlovic; Emma Magavern; Gianfranco Sinagra; Joshua W Knowles; Jonathan Myers; Euan A Ashley
Journal:  BMJ Open       Date:  2014-06-12       Impact factor: 2.692

Review 5.  Update on hypertrophic cardiomyopathy and a guide to the guidelines.

Authors:  Srijita Sen-Chowdhry; Daniel Jacoby; James C Moon; William J McKenna
Journal:  Nat Rev Cardiol       Date:  2016-09-29       Impact factor: 32.419

Review 6.  Drug Therapy for Hypertrophic Cardiomypathy: Physiology and Practice.

Authors:  Mark V Sherrid
Journal:  Curr Cardiol Rev       Date:  2016

7.  Systolic Anterior Motion of Mitral Valve Subchordal Apparatus: A Rare Echocardiographic Pattern in Non-Obstructive Hypertrophic Cardiomyopathy.

Authors:  Jezreel L Taquiso; Stephanie Martha O Obillos; Joerelle V Mojica; Lauro L Abrahan; Elleen C Cunanan; Jaime Alfonso M Aherrera; Jose Donato A Magno
Journal:  Cardiol Res       Date:  2017-10-27

8.  The Disappearing Murmur: Systolic Anterior Motion of the Mitral Valve Leaflet in a Non-hypertrophic Cardiomyopathy Patient.

Authors:  Syed Rafay Ali Sabzwari; James R Kimber; Hiwot Ayele; Nimra Khan; Tarick Sheikh; Ghulam Akbar; Bruce Feldman
Journal:  Cureus       Date:  2018-06-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.